286 related articles for article (PubMed ID: 31092896)
1. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
Watatani Y; Sato Y; Miyoshi H; Sakamoto K; Nishida K; Gion Y; Nagata Y; Shiraishi Y; Chiba K; Tanaka H; Zhao L; Ochi Y; Takeuchi Y; Takeda J; Ueno H; Kogure Y; Shiozawa Y; Kakiuchi N; Yoshizato T; Nakagawa MM; Nanya Y; Yoshida K; Makishima H; Sanada M; Sakata-Yanagimoto M; Chiba S; Matsuoka R; Noguchi M; Hiramoto N; Ishikawa T; Kitagawa J; Nakamura N; Tsurumi H; Miyazaki T; Kito Y; Miyano S; Shimoda K; Takeuchi K; Ohshima K; Yoshino T; Ogawa S; Kataoka K
Leukemia; 2019 Dec; 33(12):2867-2883. PubMed ID: 31092896
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified.
Han B; Lim S; Yim J; Song YK; Koh J; Kim S; Lee C; Kim YA; Jeon YK
J Pathol Transl Med; 2024 Mar; 58(2):59-71. PubMed ID: 38247153
[TBL] [Abstract][Full Text] [Related]
3. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
[TBL] [Abstract][Full Text] [Related]
4.
Maura F; Dodero A; Carniti C; Bolli N; Magni M; Monti V; Cabras A; Leongamornlert D; Abascal F; Diamond B; Rodriguez-Martin B; Zamora J; Butler A; Martincorena I; Tubio JMC; Campbell PJ; Chiappella A; Pruneri G; Corradini P
Haematologica; 2021 Nov; 106(11):2918-2926. PubMed ID: 33054126
[TBL] [Abstract][Full Text] [Related]
5. Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes.
Huang YH; Qiu YR; Zhang QL; Cai MC; Yu H; Zhang JM; Jiang L; Ji MM; Xu PP; Wang L; Cheng S; Zhao WL
Cell Rep Med; 2024 Feb; 5(2):101416. PubMed ID: 38350451
[TBL] [Abstract][Full Text] [Related]
6. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
[TBL] [Abstract][Full Text] [Related]
7. Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.
Zhang W; Yang P; Yang Y; Liu S; Xu Y; Wu C; Wang J; Liu C; Liu H; Li S; Huang W; Jing H
J Transl Med; 2024 May; 22(1):414. PubMed ID: 38693538
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome landscape of adult T-cell leukemia/lymphoma.
Kogure Y; Kameda T; Koya J; Yoshimitsu M; Nosaka K; Yasunaga JI; Imaizumi Y; Watanabe M; Saito Y; Ito Y; McClure MB; Tabata M; Shingaki S; Yoshifuji K; Chiba K; Okada A; Kakiuchi N; Nannya Y; Kamiunten A; Tahira Y; Akizuki K; Sekine M; Shide K; Hidaka T; Kubuki Y; Kitanaka A; Hidaka M; Nakano N; Utsunomiya A; Sica RA; Acuna-Villaorduna A; Janakiram M; Shah U; Ramos JC; Shibata T; Takeuchi K; Takaori-Kondo A; Miyazaki Y; Matsuoka M; Ishitsuka K; Shiraishi Y; Miyano S; Ogawa S; Ye BH; Shimoda K; Kataoka K
Blood; 2022 Feb; 139(7):967-982. PubMed ID: 34695199
[TBL] [Abstract][Full Text] [Related]
9. A preclinical model of peripheral T-cell lymphoma GATA3 reveals DNA damage response pathway vulnerability.
Kuczynski EA; Morlino G; Peter A; Coenen-Stass AML; Moss JI; Wali N; Delpuech O; Reddy A; Solanki A; Sinclair C; Calado DP; Carnevalli LS
EMBO Mol Med; 2022 Jun; 14(6):e15816. PubMed ID: 35510955
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice.
Amador C; Bouska A; Wright G; Weisenburger DD; Feldman AL; Greiner TC; Lone W; Heavican T; Smith L; Pileri S; Tabanelli V; Ott G; Rosenwald A; Savage KJ; Slack G; Kim WS; Hyeh Y; Li Y; Dong G; Song J; Ondrejka S; Cook JR; Barrionuevo C; Lim ST; Ong CK; Chapman J; Inghirami G; Raess PW; Bhagavathi S; Gould C; Blombery P; Jaffe E; Morris SW; Rimsza LM; Vose JM; Staudt L; Chan WC; Iqbal J
J Clin Oncol; 2022 Dec; 40(36):4261-4275. PubMed ID: 35839444
[TBL] [Abstract][Full Text] [Related]
11. The RNA sequencing results revealed the expression of different genes and signaling pathways during chemotherapy resistance in peripheral T-cell lymphoma.
Lan Y; Tao W; Ma L; Wang X; Li H; Du Y; Yang R; Wu S; Ou Y; Liu X; Huang Y; Zhou Y
BMC Med Genomics; 2024 Mar; 17(1):74. PubMed ID: 38468267
[TBL] [Abstract][Full Text] [Related]
12. Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment.
Pileri SA; Tabanelli V; Fiori S; Calleri A; Melle F; Motta G; Lorenzini D; Tarella C; Derenzini E
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572763
[TBL] [Abstract][Full Text] [Related]
13. The Role of Epigenetic Modifier Mutations in Peripheral T-Cell Lymphomas.
Tigu AB; Bancos A
Curr Issues Mol Biol; 2023 Nov; 45(11):8974-8988. PubMed ID: 37998740
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide methylation profiling of Peripheral T-cell lymphomas identifies TRIP13 as a critical driver of tumor proliferation and survival.
Nowialis P; Tobon J; Lopusna K; Opavska J; Badar A; Chen D; Abdelghany R; Pozas G; Fingeret J; Noel E; Riva A; Fujiwara H; Opavsky R
Res Sq; 2024 Feb; ():. PubMed ID: 38464090
[TBL] [Abstract][Full Text] [Related]
15. SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target.
Carty SA; Murga-Zamalloa CA; Wilcox RA
Clin Lymphoma Myeloma Leuk; 2023 Aug; 23(8):561-574. PubMed ID: 37142534
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma.
Ito Y; Marouf A; Kogure Y; Koya J; Liévin R; Bruneau J; Tabata M; Saito Y; Shingaki S; Yuasa M; Yamaguchi K; Murakami K; Weil R; Vavasseur M; Andrieu GP; Latiri M; Veleanu L; Dussiot M; André I; Joshi A; Lagresle-Peyrou C; Magerus A; Chaubard S; Lavergne D; Bachy E; Brunet E; Fataccioli V; Brouzes C; Laurent C; De Leval L; Traverse-Glehen A; Bossard C; Parrens MC; Meignin V; Philippe L; Rossignol J; Suarez F; Michot JM; Tournilhac O; Damaj G; Lemonnier F; Bôle-Feysot C; Nitschké P; Tesson B; Laurent C; Molina T; Asnafi V; Watatani Y; Chiba K; Okada A; Shiraishi Y; Tsukita S; Izutsu K; Miyoshi H; Ohshima K; Sakata S; Dobashi A; Takeuchi K; Sanada M; Gaulard P; Jaccard A; Ogawa S; Hermine O; Kataoka K; Couronné L
Cancer Res; 2024 Apr; ():. PubMed ID: 38657099
[TBL] [Abstract][Full Text] [Related]
17. Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine.
Zhang Y; Lee D; Brimer T; Hussaini M; Sokol L
Front Oncol; 2020; 10():898. PubMed ID: 32637355
[TBL] [Abstract][Full Text] [Related]
18. Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.
Amador C; Greiner TC; Heavican TB; Smith LM; Galvis KT; Lone W; Bouska A; D'Amore F; Pedersen MB; Pileri S; Agostinelli C; Feldman AL; Rosenwald A; Ott G; Mottok A; Savage KJ; de Leval L; Gaulard P; Lim ST; Ong CK; Ondrejka SL; Song J; Campo E; Jaffe ES; Staudt LM; Rimsza LM; Vose J; Weisenburger DD; Chan WC; Iqbal J
Blood; 2019 Dec; 134(24):2159-2170. PubMed ID: 31562134
[TBL] [Abstract][Full Text] [Related]
19. T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.
Ghione P; Faruque P; Mehta-Shah N; Seshan V; Ozkaya N; Bhaskar S; Yeung J; Spinner MA; Lunning M; Inghirami G; Moskowitz A; Galasso N; Ganesan N; van der Weyden C; Ruan J; Prince HM; Trotman J; Advani R; Dogan A; Horwitz S
Blood Adv; 2020 Oct; 4(19):4640-4647. PubMed ID: 33002132
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
